Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency

Allen Jeremias,Deepak L. Bhatt,Derek P. Chew,Khaled M. Ziada,Abdulhay Albirini,Sorin J. Brener,A. Michael Lincoff,Eric J. Topol,Stephen G. Ellis

Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency

2002

Allen Jeremias
Deepak L. Bhatt
Derek P. Chew
Khaled M. Ziada
Abdulhay Albirini
Sorin J. Brener
A. Michael Lincoff
Eric J. Topol
Stephen G. Ellis

In summary, this study suggests that the use of abciximab in patients with chronic renal dysfunction undergoing PCI is relatively safe and not associated with an increased risk of major bleeding.

Keywords:

Percutaneous coronary intervention
Abciximab
Cardiology
Intensive care medicine
Kidney disease
Medicine
Diabetes mellitus
Chemotherapy
Internal medicine
in patient
Surgery
Conventional PCI
Coronary artery disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations